Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAIV Impact on Mucosal Immunity in Sleep Apnea Patients
NCT07093281Phase 4Not yet recruiting
- Sponsor
- University of Maryland, Baltimore
- Start
- Feb 2027
- Primary completion
- Apr 2028
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of live attenuated influenza vaccine in influenza, sponsored by University of Maryland, Baltimore. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07093281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07093281.